ArticleBritish journal of cancer2005

Prognostic impact of FAS/CD95/APO-1 in urothelial cancers: decreased expression of Fas is associated with disease progression.

K Yamana et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.